FDA Inspection 1182009 — Versiti Blood Health, Inc.
The FDA completed an inspection of Versiti Blood Health, Inc. on October 13, 2022 in Hilliard, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 13, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Hilliard, OH (United States)